Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
August 6, 2013 -- Allium Medical of Israel signed up Beijing King Health Investment to distribute the company’s urinary tract stents in China. King Health agreed to buy at least $16 million of Allium’s stents during the eight-year run of the contract. The two companies expect to launch the urinary stents in 2016, assuming CFDA approval. More details....
Stock Symbol: (TASE: ALMD)
Help employers find you! Check out all the jobs and post your resume.
